Signal transducer and activator of transcription factor 6 (Stat6)- deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production

Journal of Experimental Medicine

Volumn 187, Issue 6, 1998, Pages 939-948

  Kuperman, Douglas ^a   Schofield, Brian ^a   Wills Karp, Marsha ^a   Grusby, Michael J ^b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; STAT PROTEIN; TRANSCRIPTION FACTOR 6; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; FEMALE; GENE DISRUPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS; BRONCHIAL HYPERREACTIVITY; EOSINOPHILIA; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032536837     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.6.939     Document Type: Article

References (47)

1. Robinson, D.S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. Bentley, C. Corrigan, S. Durham, and B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
2. Walker, C., E. Bode, L. Boer, T. Hansel, K. Blaser, and J. Johann-Christian Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
3. Del Prete, G.F., M. De Carli, M.M. D'Elios, P. Maestrelli, M. Ricci, L. Fabbri, and S. Romagnini. 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23:1445-1449.
4. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.R. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
5. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Montovani. 1989. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701-705.
6. Finkelman, F.D., I.M. Katona, J.F. Urban, Jr., J. Holmes, J. Ohara, A.S. Tung, J.G. Sample, and W.E. Paul. 1988. Interleukin-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335-2341.
7. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
8. Gavett, S.H., D.J. O'Hearn, X. Li, S. Huang, F.D. Finkelman, and M. Wills-Karp. 1995. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.
9. Brusselle, G., J. Kips, G. Joos, H. Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254-259.
10. Gavett, S.H., D.J. O'Hearn, C.L. Karp, E.A. Patel, B.H. Schofield, F.D. Finkelman, and M. Wills-Karp. 1997. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 272: L253-L261.
11. Lukacs, N.W., R.M. Strieter, S.W. Chensue, and S.L. Kunkel. 1994. Interleukin-4 dependent pulmonary eosinophil infiltration in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 10:526-532.
12. Swain, S.L., A.D. Weinberg, M. Inglish, and G. Hutson. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
13. Schleimer, R.P., S. Sterbinsky, and S. Kaiswer. 1992. IL-4 induced adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148:1086-1092.
14. Madden, K.B., J.F. Urban, H.J. Ziltener, J.W. Schrader, F.D. Finkelman, and I.M. Katona. 1991. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147:1387-1391.
15. Coyle, A.J., G. Le Gros, C. Bertrand, S. Tsuyuki, C.H. Heusser, M. Kopf, and G.P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54-59.
16. Corry, D.B., H.G. Folkesson, M.L. Warnock, D.J. Erle, M.D. Matthay, J.P. Wiener-Kronish, and R.M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
17. Lin, J.-X., T.-S. Migone, M. Friedman, J.A. Weatherbee, L. Zhou, A. Yamauchi, E.T. Bloom, J. Mietz, S. John, and W.J. Leonard. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotrophy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 2:331-339.
18. Johnston, J.A., M. Kawamura, R.A. Kirken, Y.-Q. Chen, T.B. Blake, K. Shibuya, J.R. Ortaldo, D.W. McVicar, and J.J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature. 370:151-153.
19. Witthuhn, B.A., O. Silvennoinen, O. Miura, K.S. Lai, C. Cwik, E. Liu, and J.N. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 370:153-157.
20. Keegan, A.D., K. Nelms, L. Wang, J.H. Pierce, and W.E. Paul. 1994. Interleukin-4 receptor: signaling mechanisms. Immunol. Today. 15:423-431.
21. Sun, X.L., L.-M. Wang, Y. Zhang, L. Yenush, M.G. Myers, Jr., E. Glasheen, W.S. Lane, J.H. Pierce, and M.F. White. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-177.
22. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:313-319.
23. Shimoda, K., J. Van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:630-633.
24. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380:627-630.
25. Sears, M.R., B. Burrows, E.M. Flannery, G. Herbison, C.J. Hewitt, and M.D. Hodaway. 1991. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325:1067-1071.
26. Golding, B., M. Zaitseva, and H. Golding. 1994. The potential for recruiting immune responses toward type-1 or type-2 help. Am. J. Trop. Med. Hyg. 50:33-40.
27. Rankin, J.A., D.E. Picarella, G.P. Geba, U. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R.A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA. 93:7821-7825.
28. Temann, U.-A., B. Prasad, M.W. Gallup, C. Basbaum, S.B. Ho, R.A. Flavell, and J.A. Rankin. 1997. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16:471-478.
29. Bradding, P., Y. Okayama, P.H. Howartth, M.K. Church, and S.T. Holgate. 1995. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155:297-307.
30. Brown, M.A., J.H. Pierce, C.J. Watson, J. Falco, J.N. Ihle, and W.E. Paul. 1987. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Clin. Sci. 68:427-432.
31. Korsgren, M., J.S. Erjefalt, O. Korsgren, F. Sundler, and C.G.A. Persson. 1997. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J. Exp. Med. 185:885-892.
32. Mehlhop, P.D., M. Van de Rijn, A.B. Goldberg, J.P. Brewer, V.P. Kurup, T.R. Martin, and H.C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. USA. 1344-1349.
33. Wardlaw, A.J., S. Dunnette, G.J. Gleich, J.V. Collins, and A.B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
34. Frigas, E., D.A. Loegering, and G.J. Gleich. 1980. Cytotoxic effects of the guinea pig derived major basic protein on tracheal epithelium. Lab. Invest. 42:35-43.
35. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.R. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
36. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasatsu, and T. Suda. 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1737-1742.
37. Palmer-Crocker, R.L., C.C.W. Hughes, and J.S. Pober. 1996. IL-4 and IL-13 activate the JAK2 tyrosine and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the γc chain. J. Clin. Invest. 98:604-609.
38. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1145-1154.
39. Van Oosterhout, A.J., A.R. Ladenius, H.F. Savelkoul, I. Van Ark, K.C. Delsman, and F.P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548-552.
40. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
41. Kraneveld, A.D., F.P. Nijkamp, and A.J.M. Van Oosterhout. 1997. Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. Am. J. Respir. Crit. Care Med. 156:367-374.
42. Aikawa, T., S. Shimura, S. Hidetada, M. Ebina, and T. Takishima. 1992. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 101:916-921.
43. Larivee, P., S.J. Levine, R.D. Rieves, and J.H. Shelhamer. 1994. Airway inflammation and mucus hypersecretion. In Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion. S. Shimura and T. Takishima, editors. Marcel Dekker, New York. 469-511.
44. Huang, S.K., H.Q. Xiao, J. Kleince-Tebbe, G. Paciotti, D.G. Marsh, L.M. Lichtenstein, and M.C. Liu. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155:2688-2694.
45. Patel, B.K.R., L. Wang, C. Lee, W.G. Taylore, J.H. Pierce, and W.J. LaRochelle. 1996. Stat6 and Stat1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J. Biol. Chem. 271:22175-22182.
46. Chanez, P., M. Vignola, R. Stenger, P. Vic, F.B. Michel, and J. Bousquet. 1995. Platelet-derived growth factor in asthma. Allergy. 50:878-883.
47. Aubert, J.D., S. Hayashi, J. Hards, T.R. Bai, P.D. Pare, and J.C. Hogg. 1994. Platelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstruction. Am. J. Physiol. 266:L655-L663.